Literature DB >> 10399266

[De novo formation of a cavernoma in association with a preformed venous malformation during immunosuppressive treatment].

M Brunken1, S Sagehorn, A Leppien, A Müller-Jensen, E Halves.   

Abstract

We report the clinical course of a 48 year old woman, who underwent a cranial MRI-examination in 1995, which confirmed the diagnosis of encephalomyelitis disseminata, but also showed a left temporal venous malformation without evidence of prior hemorrhage. Three month after immunosuppressive treatment with Methotrexate in 1997 begun, first hemorrhage in the left temporal lobe occurred with de novo formation of a cavernoma in association to the known venous malformation. The lesion was totally removed after stereotactic guided craniotomy without any complication. The pathogenetic relationship of de novo cavernomas and associated venous malformations and the remarkable association with immunosuppressive treatment will be discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399266

Source DB:  PubMed          Journal:  Zentralbl Neurochir        ISSN: 0044-4251


  3 in total

1.  De Novo Cavernous Malformation Associated with a Pre-existing Developmental Venous Anomaly : Could Magnetic Resonance Findings Predict Evolution?

Authors:  Daniel García-Pérez; Irene Panero; Alfonso Lagares; Pedro González
Journal:  Clin Neuroradiol       Date:  2019-05-31       Impact factor: 3.649

2.  Brain cavernomas associated with en coup de sabre linear scleroderma: Two case reports.

Authors:  Emily T Fain; Melissa Mannion; Elena Pope; Daniel W Young; Ronald M Laxer; Randy Q Cron
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-29       Impact factor: 3.054

3.  De novo formation of cerebral cavernous malformation adjacent to existing developmental venous anomaly - an effect of change in venous pressure associated with management of a complex dural arterio-venous fistula.

Authors:  Hariprakash Chakravarthy; Tzu-Kang Lin; Yao-Liang Chen; Yi-Ming Wu; Chin-Hua Yeh; Ho-Fai Wong
Journal:  Neuroradiol J       Date:  2016-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.